# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Andes Technology and Arteris partnership aims to support the growing adoption of RISC-V SoCs by mutual customers. Focus is o...
Jefferies analyst Blayne Curtis downgrades Arteris (NASDAQ:AIP) from Buy to Hold and lowers the price target from $11 to $9.
Rosenblatt analyst Hans Mosesmann reiterates Arteris (NASDAQ:AIP) with a Buy and maintains $15 price target.
Arteris (NASDAQ:AIP) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.16) by 6.2...